Zentexia offers contract research partnerships based on the strong capabilities within artificial intelligence and in silico modulation to enhance our client's succes during all stages of preclinical and early clinical development. 

In relation to internal programs, Zentexia interacts with potential partners at an early stage of development to verify the commercial viability of a project. We invite potential partners to interact with us based on the therapeutic areas of interest.

Zentexia offers a flexible and lean licensing model, where partnerships can be entered at multiple levels of development.